Dyslipemia 📌Cornerstone in CV risk management 📌Put theory into practice 📌Combination therapy to achieve goals 📌Main comorbidities⬆️risk: address all together to improve results & outcomes #ESCCongress #ESC24_Sanofi_ES Sanofi España Contenido dirigido a profesionales sanitarios

What a fascinating #ESCCongress we’ve had in London! ✍️Glad to have been part of the biggest scientific experience of 2024 ✍️Anxious to host you all in #ESC2025 #Esccongress2025 in Madrid ✍️Abstract deadline february 14th 2025 #cardioX #ESC_guidelines #ESC_TV #laSECtelleva

Non-HDLc⬇️ 📌Challenges/prognosis applying clinical trial results➡️real world 📌Insights from SWEDEHEART registry⬇️non-HDLc post MI ✅EARLY ✅STRIKE ✅STRONG ✅SUSTAINED Contenido dirigido a profesionales sanitarios doi.org/10.1093/eurhea… #ESCCongress #ESC24_Sanofi_ES Sanofi España

Obesity insights from #ESCCongress 📌Clinical consensus statement 📌Summary of data from 'holistic' agents on ✅Heart Failure ✅Diabetes ✅Chronic Kidney Disease 📌New publications on blood pressure efects of Semaglutide 📌Dr VictorGirbés interview #GLP1 #lifestyle #cardioX #CardioED

Aortic & PAD guidelines (Part 1) 📌Key messages & gap evidences (📷) 📌Not just ‘patient centered‘: Françoise Steinbach represents ESC Patient Forum 📌From ‘Heart Team’ to ‘Aortic Team’ #ESCCongress Contenido dirigido a profesionales sanitarios #ESC24_sanofi_ES Sanofi España

London #ESCCongress brings the curtain down 🙏4 incredible days full of science 🙏Fantastic European Society of Cardiology coverage & daily wrap-ups 🙏2025 will join European + World Cardiology Congresses #WCCardio World Heart Federation 🙏Hope to see you in Madrid 29/8-1/9/25 #ESC_Guidelines #laSECtelleva

Microbiota y Enfermedad Cardiovascular 🫀Una relación demostrada ✅Endocarditis infecciosa ✅Enfermedad periodontal & infarto miocardio ✅Dislipemia disbiótica & colelitiasis ✅Receptores GLP1 & obesidad youtu.be/L_KgvfR6P3s?si… #gutmicrobioma #inflammation #obesity #ESCCongress

Updated registration San Marino Cup 🇵🇭Jasmine Althea Ramilo 🇨🇱Maite Urrutia 🇨🇱Montserrat Urrutia 🇮🇹Anna Piergentili 🇦🇿Fidan Gurbanli retires her participation 📽️Streaming youtube.com/@federazionesa… #Rhythmicgymnastics #gimnasiaritmica #ginnasticaritmica #gymnastics FIG

Aortic & PAD guidelines (Part 2) 📌One of main headings contains key holistic #ESCCongress learnings 📌Polyvascular PAD & PAD in patients with cardiac diseases ✅Screening & multifactorial risk approach ✅Intensive lifestyle modification ✅Optimal treatment #HF #AF #CAD #Cardiox

«Aunque no tengas nada que cosechar nunca te canses de sembrar». Madre Teresa de Calcuta #santodeldia #madreteresadecalculta #madreteresa #santateresadecalcuta

SWIRL&TWIRL IT 📌2024-2025 #rhythmicgymnastics season has just begun 📌New 2025-2028 cop exercises to be released (with A/E 2022-2024 COP scoring) 🇮🇹Tara Dragas 🇮🇹Isabel Rocco 🇮🇹Gaia Mancini 🇮🇹Chiara Puosi 🇦🇺Asya Seker 🇱🇺Amandine Simon #gymnastics FIG #ASUudinese #RG

Inflammation in cardiovascular disease 📌Classification of human atherosclerotic plaques 📌Basic biology of RNA plaque expression 📌Varying gene expresion➡️different clinical presentation 📌An #ESCwebinar not to miss 📌Free registration esc365.escardio.org/event/1604 #atherosclerosis

Aortic & PAD Guidelines (Part 3) 📌It's important to learn what to do 📌But is mandatory to learn what you musn't do 📌New recommendations include class III statements involving ✅Lipid-lowering therapies ✅Physical exercise ✅Imaging assessment ✅Invasive treatment #ESCCongress

Navigating diagnosis/management PAD: latest guidelines #ESCwebinar with Pretest Evaluation 📅11/9 18-19h 🗣️Lucía Mazzolai 🗣️Marianne Brodmann 🗣️Stephano Lanzi 📌Appropriate exercise prescription 📌Latest pharmacological treatments 📌Long-term outcomes youtu.be/uIZVQ5fYFbs

Mensajes contundentes a la población 📌Bien por exponer la realidad del riesgo cardiovascular 📌¿Promocionar score de calcio como método de cribado? Comparto mi reflexión Espero la vuestra en comentarios linkedin.com/feed/update/ur… #cardiox #CardioEd #cardiovascularscreening

Repost Borge G Nordestgaard 📌Lipoprotein(a) and cardiovascular disease 📌Review just published The Lancet 📌50 days' free access authors.elsevier.com/a/1jlsNV-4XOtaS 📌Measure Lp(a) in all once in a lifetime 📌Stay tuned for coming Lp(a)-lowering therapy x.com/BNordestgaard/… #CardioEd #Cardiox

«Los deportes minoritarios están en clara desventaja porque no tienen tan fácil acceso a reconocimientos médicos como otros deportes» ✅Así lo contamos en la VIII edición ✅En marcha X Congreso Nacional Muerte Súbita 📆8/11 Barcelona ¿Te lo vas a perder? youtu.be/HF5TAXVG7po

Cardiovascular benefit 📌SGLT-2i & GLP1ar consistently show CV benefits 📌Guidelines/consensus recommend combination of both drugs 📌Recent research presented at #EASD2024 show CV benefits of Empagliflozin + DPP4i 📌However, DPP4i & GLP1ar cannot be combined How to choose combos?

Disponible listado equipos liga clubes Iberdrola GR 2025 📌3 divisiones 📌51 clubes nominales + 📌3 clubes acceso control A por una (otra) temporada excepcional #gimnasiaritmica #creervaleoro #ligaiberdrola #teamESP #ginnasticaritmica #rhythmicgymnastics #gimnasia #gymnastics